微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.12% | 143.41% | 110.46% | 78/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2025-12-31 | -10.71% | -91.59% | -200.84% | 122/141 | 2.37% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-09-30 | -3.56% | -48.95% | -37.98% | 121/141 | 4.19% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-06-30 | -2.58% | -27.72% | -360.61% | 118/141 | 2.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-03-31 | 0.99% | 193.4% | 117.71% | 72/141 | 1.42% | 惠泰医疗 | 15.03% | 行业排名> |
| 2024-12-31 | -5.59% | 12.24% | -133.89% | 115/141 | 4.14% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-09-30 | -2.39% | 31.32% | -18.32% | 116/141 | 5.03% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-06-30 | -2.02% | 33.77% | -90.57% | 120/141 | 3.15% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-03-31 | -1.06% | -43.24% | 83.36% | 119/141 | 1.75% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2023-12-31 | -6.37% | -2.41% | -83.05% | 121/141 | 5.44% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-09-30 | -3.48% | -157.78% | -14.1% | 118/141 | 6.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-06-30 | -3.05% | -53.27% | -312.16% | 123/141 | 3.96% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-03-31 | -0.74% | -48% | 88.1% | 114/141 | 2.33% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2022-12-31 | -6.22% | -1103.23% | -360.74% | 123/141 | 13.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-09-30 | -1.35% | -104.52% | 32.16% | 112/141 | 13.94% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | -1.99% | -110.46% | -298% | 119/141 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2022-03-31 | -0.5% | -103.26% | -180.65% | 105/141 | 6.8% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 0.62% | -96.76% | -97.92% | 119/141 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-09-30 | 29.85% | 45.47% | 56.94% | 12/141 | 16.59% | 热景生物 | 121.78% | 行业排名> |
| 2021-06-30 | 19.02% | 171.71% | 24.15% | 15/141 | 11.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-03-31 | 15.32% | 801.18% | -19.87% | 8/141 | 6.49% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 19.12% | 227.96% | -6.82% | 55/141 | 26.27% | 热景生物 | 57.63% | 行业排名> |
| 2020-09-30 | 20.52% | 342.24% | 193.14% | 26/141 | 19.98% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 7% | 152.71% | 311.76% | 59/141 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-03-31 | 1.7% | 39.34% | -70.84% | 46/141 | 3.31% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 5.83% | -30.43% | 25.65% | 93/141 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-09-30 | 4.64% | -48.62% | 67.51% | 50/141 | 10.54% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 2.77% | -60.26% | 127.05% | 55/141 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-03-31 | 1.22% | -69.58% | -85.44% | 40/141 | 2.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 8.38% | -43.64% | -7.2% | 77/141 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2018-09-30 | 9.03% | -24.81% | 29.56% | 29/141 | 9.71% | 安旭生物 | 48.71% | 行业排名> |
| 2018-06-30 | 6.97% | -12.44% | 73.82% | 20/141 | 4.54% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-03-31 | 4.01% | 2.04% | -73.03% | 14/141 | 2.78% | *ST明德 | 14.54% | 行业排名> |
| 2017-12-31 | 14.87% | 14.21% | 23.81% | 45/141 | 14.51% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-09-30 | 12.01% | 1.26% | 50.88% | 16/141 | 9.49% | 安旭生物 | 59.22% | 行业排名> |
| 2017-06-30 | 7.96% | 19.7% | 102.54% | 18/141 | 6.11% | 大博医疗 | 30.55% | 行业排名> |
| 2017-03-31 | 3.93% | 6.22% | -69.82% | 9/141 | 2.74% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 13.02% | -12.62% | 9.78% | 46/141 | 16.44% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-09-30 | 11.86% | -7.27% | 78.35% | 8/141 | 8.86% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 6.65% | -10.62% | 79.73% | 19/141 | 6.35% | 安图生物 | 28% | 行业排名> |
| 2016-03-31 | 3.7% | -3.39% | -75.17% | 4/141 | 2.3% | *ST明德 | 23.29% | 行业排名> |